Atlas Trials

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Clinical trial NCT04225923 · COMPLETED

Trial details

NCT number
NCT04225923
Sponsor
Nobelpharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cytomegalovirus Disease
Start date
2020-06-01
Primary completion
2022-11-02
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.